These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 36727624)

  • 1. Nanogels co-loading paclitaxel and curcumin prepared
    Song X; Feng Z; Peng Y; Yu S; Du X; Huang P; Wang W; Xing J
    J Mater Chem B; 2023 Feb; 11(8):1798-1807. PubMed ID: 36727624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanogels loading curcumin
    Peng Y; Yu S; Wang Z; Huang P; Wang W; Xing J
    J Mater Chem B; 2022 May; 10(17):3293-3302. PubMed ID: 35380157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-delivery of paclitaxel and curcumin by biodegradable polymeric nanoparticles for breast cancer chemotherapy.
    Xiong K; Zhang Y; Wen Q; Luo J; Lu Y; Wu Z; Wang B; Chen Y; Zhao L; Fu S
    Int J Pharm; 2020 Nov; 589():119875. PubMed ID: 32919003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy.
    Alemi A; Zavar Reza J; Haghiralsadat F; Zarei Jaliani H; Haghi Karamallah M; Hosseini SA; Haghi Karamallah S
    J Nanobiotechnology; 2018 Mar; 16(1):28. PubMed ID: 29571289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exceedingly Higher co-loading of Curcumin and Paclitaxel onto Polymer-functionalized Reduced Graphene Oxide for Highly Potent Synergistic Anticancer Treatment.
    Muthoosamy K; Abubakar IB; Bai RG; Loh HS; Manickam S
    Sci Rep; 2016 Sep; 6():32808. PubMed ID: 27597657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin and Paclitaxel Co-loaded Heparin and Poloxamer P403 Hybrid Nanocarrier for Improved Synergistic Efficacy in Breast Cancer.
    Nguyen NT; Bui QA; Huynh PD; Nguyen QH; Tran NQ; Viet NT; Nguyen DT
    Curr Drug Deliv; 2022 Aug; 19(9):966-979. PubMed ID: 35366771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-targeted enzyme-sensitive hyaluronic acid nanogels loading paclitaxel for the therapy of breast cancer.
    Gao D; Asghar S; Ye J; Zhang M; Hu R; Wang Y; Huang L; Yuan C; Chen Z; Xiao Y
    Carbohydr Polym; 2022 Oct; 294():119785. PubMed ID: 35868795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smart Polymeric Nanoparticles with pH-Responsive and PEG-Detachable Properties (II): Co-Delivery of Paclitaxel and VEGF siRNA for Synergistic Breast Cancer Therapy in Mice.
    Jin M; Hou Y; Quan X; Chen L; Gao Z; Huang W
    Int J Nanomedicine; 2021; 16():5479-5494. PubMed ID: 34413645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An improved method in fabrication of smart dual-responsive nanogels for controlled release of doxorubicin and curcumin in HT-29 colon cancer cells.
    Abedi F; Davaran S; Hekmati M; Akbarzadeh A; Baradaran B; Moghaddam SV
    J Nanobiotechnology; 2021 Jan; 19(1):18. PubMed ID: 33422062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-delivery of Pirarubicin and Paclitaxel by Human Serum Albumin Nanoparticles to Enhance Antitumor Effect and Reduce Systemic Toxicity in Breast Cancers.
    Yi X; Lian X; Dong J; Wan Z; Xia C; Song X; Fu Y; Gong T; Zhang Z
    Mol Pharm; 2015 Nov; 12(11):4085-98. PubMed ID: 26422373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic Acid-Modified Nanoerythrocyte for Codelivery of Paclitaxel and Tariquidar to Overcome Breast Cancer Multidrug Resistance.
    Zhong P; Chen X; Guo R; Chen X; Chen Z; Wei C; Li Y; Wang W; Zhou Y; Qin L
    Mol Pharm; 2020 Apr; 17(4):1114-1126. PubMed ID: 32176509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomal co-delivery of curcumin and albumin/paclitaxel nanoparticle for enhanced synergistic antitumor efficacy.
    Ruttala HB; Ko YT
    Colloids Surf B Biointerfaces; 2015 Apr; 128():419-426. PubMed ID: 25797481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-delivery of paclitaxel and STAT3 siRNA by a multifunctional nanocomplex for targeted treatment of metastatic breast cancer.
    Luo K; Gao Y; Yin S; Yao Y; Yu H; Wang G; Li J
    Acta Biomater; 2021 Oct; 134():649-663. PubMed ID: 34289420
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Huang C; Chen F; Zhang L; Yang Y; Yang X; Pan W
    Int J Nanomedicine; 2020; 15():2987-2998. PubMed ID: 32431497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pH multistage responsive micellar system with charge-switch and PEG layer detachment for co-delivery of paclitaxel and curcumin to synergistically eliminate breast cancer stem cells.
    Yang Z; Sun N; Cheng R; Zhao C; Liu Z; Li X; Liu J; Tian Z
    Biomaterials; 2017 Dec; 147():53-67. PubMed ID: 28930649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-lung cancer effect of paclitaxel solid lipid nanoparticles delivery system with curcumin as co-loading partner in vitro and in vivo.
    Pi C; Zhao W; Zeng M; Yuan J; Shen H; Li K; Su Z; Liu Z; Wen J; Song X; Lee RJ; Wei Y; Zhao L
    Drug Deliv; 2022 Dec; 29(1):1878-1891. PubMed ID: 35748365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy.
    Guo W; Song Y; Song W; Liu Y; Liu Z; Zhang D; Tang Z; Bai O
    Sci Rep; 2020 May; 10(1):7832. PubMed ID: 32398729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation Of Nanobubbles Modified With A Small-Molecule CXCR4 Antagonist For Targeted Drug Delivery To Tumors And Enhanced Ultrasound Molecular Imaging.
    Peng Y; Zhu L; Wang L; Liu Y; Fang K; Lan M; Shen D; Liu D; Yu Z; Guo Y
    Int J Nanomedicine; 2019; 14():9139-9157. PubMed ID: 32063704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted nanogel conjugate for improved stability and cellular permeability of curcumin: synthesis, pharmacokinetics, and tumor growth inhibition.
    Wei X; Senanayake TH; Bohling A; Vinogradov SV
    Mol Pharm; 2014 Sep; 11(9):3112-22. PubMed ID: 25072100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-Delivery of Curcumin and Paclitaxel by "Core-Shell" Targeting Amphiphilic Copolymer to Reverse Resistance in the Treatment of Ovarian Cancer.
    Zhao MD; Li JQ; Chen FY; Dong W; Wen LJ; Fei WD; Zhang X; Yang PL; Zhang XM; Zheng CH
    Int J Nanomedicine; 2019; 14():9453-9467. PubMed ID: 31819443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.